Search results
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 8 hours agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company sells. There ...
Trump, in hostile territory, faces booing during Libertarian Party convention as members pick their...
Fox News· 9 hours agoTrump was met with a crowd of repeated booing during his speech at the Libertarian Party convention...
COVID-19 test maker Cue Health — once worth $2.3B — lays off entire company and shuts down
Orange County Register· 3 days agoCue Health, the once high-flying San Diego biotech supplying rapid COVID-19 test kits to the NBA and...
This Stock Has Gained 150% Since I Bought It – but It Could Still Be a Bargain
Motley Fool via Yahoo Finance· 7 hours agoWells Fargo (NYSE: WFC) was one of the best opportunistic investments I've ever made. I bought the...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 7 hours agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...
Covid-19 Infections On Rise In Los Angeles And Statewide
Deadline Hollywood· 20 hours agoNew variants are pushing the infection rates slightly higher, officials said.
Box Office Meltdown: ‘Garfield’ Claims Victory Over ‘Furiosa’ With Worst No. 1 Memorial Day Opening...
The Hollywood Reporter via Yahoo News· 2 hours agoThe Memorial Day box office is no picnic this year. Alcon and Sony’s The Garfield Movie is claiming...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...
'It's dire': How the nursing home industry continues to struggle in Illinois
Gannett via AOL· 9 hours agoIt’s been four years since some of the worst scenes of COVID-19 played out in locked-down nursing...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA Today· 4 days agoWhen COVID-19 vaccines entered the commercial market last fall, the federal government introduced a...